← Leaderboards
Lisa B Vanwagner
Northwestern University At Chicago
$4,462,272
Attributed
$4,462,272
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,462,272 · 5
By mechanism
R01$2,809,843 · 2
R56$774,116 · 1
K23$756,647 · 1
F32$121,666 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Rupal Mehta$999,759
- Xunrong Luo$22,077,409
- Juan C Caicedo$1,755,518
- William H Pearce$1,640,537
- Gokhan M. Mutlu$14,664,662
Others in their field
Top investigators on “Liver Transplantation”
- John C Magee · University Of Michigan At Ann Arbor$32,824,292
- Robert M Merion · University Of Michigan At Ann Arbor$32,380,845
- Jeffrey S Glenn · Stanford University$29,122,918
- Peter G Stock · University Of California San Francisco$27,203,354
- William M Lee · University Of Texas Sw Med Ctr/Dallas$24,215,692
- Dorry Segev · Johns Hopkins University$23,097,210
Research focus
Liver TransplantationTransplantationDesignPatient PopulationMultidisciplinarySurveysLiver DiseasesUniversitiesMemberCardiovascular DiseasesRisk FactorsResourcesResearch PersonnelMedicineHigh RiskEventFutureCardiovascular SystemHypertensionTransplant RecipientsMorbidity - Disease RateFocus GroupsComorbidityFunding
Grant awards (13)
Avoiding Cardiovascular Complications in Liver Transplantation through Novel Studies (ACCT NOW) in Hypertension$727,222
R01 · FY2025 · HL · contact PI
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease$430,228
R01 · FY2025 · AA · contact PI
Avoiding Cardiovascular Complications in Liver Transplantation through Novel Studies (ACCT NOW) in Hypertension$806,550
R01 · FY2024 · HL · contact PI
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease$424,668
R01 · FY2024 · AA · contact PI
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease$421,175
R01 · FY2023 · AA · contact PI
Blood pressure as a modifiable risk factor for cardiovascular events in liver transplant recipients$407,519
R56 · FY2021 · HL · contact PI
Blood pressure as a modifiable risk factor for cardiovascular events in liver transplant recipients$366,597
R56 · FY2021 · HL · contact PI
Implementation science to improve cardiovascular outcomes among liver transplant recipients$189,251
K23 · FY2020 · HL · contact PI
Implementation science to improve cardiovascular outcomes among liver transplant recipients$189,643
K23 · FY2019 · HL · contact PI
Implementation science to improve cardiovascular outcomes among liver transplant recipients$189,319
K23 · FY2018 · HL · contact PI
Implementation science to improve cardiovascular outcomes among liver transplant recipients$188,434
K23 · FY2017 · HL · contact PI
Derivation and validation of a cardiac risk index in liver transplantation$59,432
F32 · FY2013 · HL · contact PI
Derivation and validation of a cardiac risk index in liver transplantation$62,234
F32 · FY2012 · HL · contact PI